• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Difficult or Delayed Positioning (1157); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/06/2019
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that stent elongation occurred.The 100% stenosed, focal target lesion was located in the moderately tortuous and moderately calcified superficial femoral artery (sfa).Following pre-dilation with a non-bsc balloon, a 6 x 120 x 130 eluvia drug-eluting vascular stent system was advanced contralateral over a.014 unknown guidewire and deployed with no issues.A second 6 x 120 x 130 eluvia drug-eluting vascular stent system was then selected and advanced to the lesion.During stent deployment, movement of the thumbwheel was not good from the beginning.For the remaining 4-5cm, the thumbwheel became considerably hard.The thumbwheel was rotated with force and was able to place the stent.However, the stent became elongated.A third eluvia drug-eluting vascular stent system (7x40) was placed over a.035 guidewire and stent deployment was completed without any problems.The procedure was concluded.There were no patient complications.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Device is a combination product.Device evaluated by mfr: returned product consisted of an eluvia self-expanding stent system with a 0.014" guidewire stuck in the device.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the yellow thumbwheel lock and luer was missing.The stent was deployed.There was a kink on the outer sheath at the nosecone.The guidewire was sticking out 24.5cm from the tip and 34cm from the pull rack.The pull rack measured 15.6cm from the handle to the knob.Microscopic examination did not reveal any damages.There was blood present inside the middle sheath and the middle sheath appears cloudy.Operations engineering opened the handle and the proximal inner appears to have prolapsed.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Event Description
It was reported that stent elongation occurred.The 100% stenosed, focal target lesion was located in the moderately tortuous and moderately calcified superficial femoral artery (sfa).Following pre-dilation with a non-bsc balloon, a 6 x 120 x 130 eluvia drug-eluting vascular stent system was advanced contralateral over a.014 unknown guidewire and deployed with no issues.A second 6 x 120 x 130 eluvia drug-eluting vascular stent system was then selected and advanced to the lesion.During stent deployment, movement of the thumbwheel was not good from the beginning.For the remaining 4-5cm, the thumbwheel became considerably hard.The thumbwheel was rotated with force and was able to place the stent.However, the stent became elongated.A third eluvia drug-eluting vascular stent system (7x40) was placed over a.035 guidewire and stent deployment was completed without any problems.The procedure was concluded.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8450100
MDR Text Key139805142
Report Number2134265-2019-02710
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/18/2020
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0023064517
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/21/2019
Initial Date Manufacturer Received 03/06/2019
Initial Date FDA Received03/25/2019
Supplement Dates Manufacturer Received03/29/2019
Supplement Dates FDA Received04/04/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-